Related Experiment Video
Updated: Jul 4, 2025

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
RARRES2 is involved in the "lock-and-key" interactions between osteosarcoma stem cells and tumor-associated
Jingjin Ma1, Zhiyu Chen1, Qiaochu Li1
1Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Abstract:
Osteosarcoma (OS) is a type of tumor. Osteosarcoma stem cells (OSCs) are responsible for drug resistance, recurrence, and immunosuppression in OS. We aimed to determine the heterogeneity of OSCs and the immunosuppression mechanisms underlying the interactions between OSCs and tumor-associated macrophages (TAMs). The cell components, trajectory changes, and cell communication profiles of OS cells were analyzed by transcriptomics at the single-cell level. The intercellular communication patterns of OSCs were verified, and the role of the cell hub genes was revealed. Hub geneS are genes that play important roles in regulating certain biological processes; they are often defined as the genes with the strongest regulatory effect on differentially expressed gene sets. Moreover, various cellular components of the OS microenvironment were identified. Malignant cells were grouped, and OSCs were identified. Further regrouping and communication analysis revealed that the genes in the stemness maintenance and differentiation subgroups were involved in communication with macrophages. Key receptor-ligand pairs and target gene sets for cell communication were obtained. Transcriptome data analysis revealed the key gene RARRES2, which is involved in intercellular communication between OSCs and TAMs. In vitro studies confirmed that macrophages promote RARRES2-mediated stemness maintenance in OSCs via the TAM-secreted cytokine insulin-like growth factor 1. Patient studies confirmed that RARRES2 could be a biomarker of OS. OSCs are highly heterogeneous, and different subgroups are responsible for proliferation and communication with other cells. The IGF-RARRES2 axis plays a key role in maintaining OSC stemness through communication with TAMs.
Insights
Osteosarcoma stem cells (OSCs) drive drug resistance and recurrence. This study reveals heterogeneity in OSCs and identifies the IGF-RARRES2 axis, involving tumor-associated macrophages, as crucial for maintaining OSC stemness.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- Osteosarcoma (OS) is a primary bone malignancy.
- Osteosarcoma stem cells (OSCs) contribute to therapeutic resistance, disease recurrence, and immune suppression.
- Understanding OSC heterogeneity and their interaction with the tumor microenvironment is critical for developing effective treatments.
Purpose of the Study:
- To investigate the heterogeneity of OSCs within the OS tumor microenvironment.
- To elucidate the immunosuppression mechanisms driven by the interaction between OSCs and tumor-associated macrophages (TAMs).
- To identify key molecular players and communication pathways involved in OSC stemness maintenance.
Main Methods:
- Single-cell transcriptomics was employed to analyze OS cell components, trajectory, and intercellular communication.
- Computational analysis identified cell communication patterns, hub genes, and malignant cell subgroups, including OSCs.
- In vitro and patient studies validated key findings, including the role of specific genes and cytokines.
Main Results:
- OSCs exhibit significant heterogeneity, with distinct subgroups involved in proliferation and intercellular communication.
- The study identified RARRES2 as a key gene mediating communication between OSCs and TAMs.
- Tumor-associated macrophages promote OSC stemness via insulin-like growth factor 1 (IGF-1) signaling, which upregulates RARRES2.
Conclusions:
- The IGF-1/RARRES2 axis is a critical pathway for maintaining OSC stemness through communication with TAMs.
- RARRES2 serves as a potential biomarker for osteosarcoma.
- Targeting the identified communication pathways may offer novel therapeutic strategies for osteosarcoma.
Related Concept Videos
The Tumor Microenvironment
Mesenchymal Stem Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

